Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Observational Non-Interventional Retrospective Program for Studying the Efficiency and Safety of Ergoferon in Patients With Influenza and Acute Respiratory Viral Infection (ARVI).

NCT04413929 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT04413929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04413929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Observational Non-Interventional Retrospective Program for Studying the Efficiency and Safety of Ergoferon in Patients With Influenza and Acute Respiratory Viral Infection (ARVI).
Lead sponsor
Materia Medica Holding
Phase
Observational
Overall status
Completed
Start date
October 31, 2016
Completion date
April 30, 2017
Enrollment
8,411 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

viral respiratory infection